The clinical impact and incidence of periocular pigmentation associated with either latanoprost or bimatoprost therapy.
To evaluate the incidence and characteristics of periocular pigmentation with latanoprost versus bimatoprost. A retrospective, active-controlled comparison of consecutive patients treated with latanoprost or bimatoprost for 12 months evaluating patients to determine the incidence, characteristics, and reversibility of periocular pigmentation. Periocular pigmentation was found in 1% patients treated with latanoprost and 6% patients treated with bimatoprost within 12 months of beginning treatment (p = 0.004). This study suggests that periocular pigmentation may develop after treatment with latanoprost or bimatoprost.